US Patent 11338031 Vaccine against RSV
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Janneke M. Verhagen0
Johannes Petrus Maria Langedijk0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113380310
Date of Patent
May 24, 2022
0Patent Application Number
169464850
Date Filed
June 24, 2020
0Patent Citations
Patent Primary Examiner
Edits on 25 May, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
Article (+409 characters)
US Patent 11338031 Vaccine against RSV
Article
The present invention relates to novel nucleic acid molecules encoding a pre-fusion RSV F protein or immunologically active part thereof, wherein the pre-fusion RSV F protein comprises the amino acid sequence of SEQ ID NO: 1 or 2. The invention further relates to the use of the nucleic acid molecules, or vectors comprising said nucleic acid molecules, as a vaccine against respiratory syncytial virus (RSV).
Infobox
Is a
Patent jurisdiction
Patent number
11338031
Date of patent
May 24, 2022
Patent application number
16946485
Date Filed
June 24, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11338031 Vaccine against RSV
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
